Navigation Links
McGill researchers discover gene that increases susceptibility to Crohn's disease
Date:1/8/2009

Researchers at McGill University, the Research Institute of the McGill University Health Centre (RI MUHC) and the McGill University and Gnome Qubec Innovation Centre, along with colleagues at other Canadian and Belgian institutions, have discovered DNA variations in a gene that increases susceptibility to developing Crohn's disease. Their study was published in the January issue of the journal Nature Genetics.

The study was led by McGill PhD candidate Alexandra-Chlo Villani under the supervision of Dr. Denis Franchimont and Dr. Thomas Hudson. Dr. Franchimont, now with the Erasme Hospital in Brussels, Belgium, was a Canada Research Chair formerly affiliated with the Gastroenterology Dept. of the MUHC. Dr. Hudson, former Director of the McGill University and Gnome Qubec Innovation Centre, is now the President and Scientific Director of the Ontario Institute for Cancer Research (OICR), located in Toronto.

The researchers pinpointed DNA sequence variants in a gene region called NLRP3 that are associated with increased susceptibility to Crohn's disease. Crohn's is a chronic relapsing inflammatory disease of the digestive system that can affect any part of the gastrointestinal tract. Patients can suffer from a number of different symptoms in various combinations, including abdominal pain, bloody diarrhea, fever, vomiting and weight loss. Rarer complications include skin manifestations, arthritis and eye inflammation.

"Although the exact cause of Crohn's disease is still unknown, both environmental and genetic factors are known to play a critical role in the pathogenesis of the disease," Dr. Franchimont said.

Crohn's disease is found throughout the world. However, it appears to be most common in North America and northern Europe, and Canada has one of the highest incidence rates in the world. Crohn's affects between 400,000 and 600,000 people in North America.

The 400 square metres of the intestinal absorptive area is the largest single surface in or on the human body, and it is covered by billions of bacteria of the intestinal microflora living in the gastrointestinal tract.

"The single layer of cells lining your intestinal digestive tract is thus constantly exposed to high levels of bacteria and pathogens," Villani explained. "These cells must recognize and respond appropriately to the harmful bacteria while maintaining tolerance to the non-pathogenic 'good' bacteria that make up your intestinal microbial flora. This is the central challenge of the digestive immune system, which needs to balance defence versus tolerance."

"The protein encoded by the Crohn's disease susceptibility gene NLRP3, cryopyrin, is an intracellular bacteria sensor that plays a key role in initiating immune response," explained Villani. Based on their results, researchers theorize the bacterial sensor cryopyrin is probably defective in some patients, and doesn't correctly recognize the presence of harmful bacteria.

"When the digestive immune system's counter-attack is insufficient to clear the threat," Ms. Villani continued, "there is a bacterial infiltration in the intestinal wall through the first line of defence mechanisms. The digestive immune system will again try to repel the threat, but the effort may not be sufficient, and this usually leads to a vicious cycle that results in chronic inflammation in the intestinal wall. And that is Crohn's disease."

"This gene also plays a central role in the regulation of fever, which is one of the most primitive defence mechanisms that exists in humans to fight the surrounding pathogenic bacteria," Dr. Hudson added. "DNA sequence variations in the NLRP3 gene are also known to be responsible for hereditary periodic fever syndromes."

"Previously published genome-wide association studies have already detected more than 30 distinct Crohn's genetic factors, but these only explain about one-fifth of Crohn's disease heritability", said Dr. Franchimont.

Though these results will not lead to any new short-term treatments for Crohn's, Dr. Franchimont is confident that in the longer term it will benefit patient care. "Studies like this one give us a better understanding of key pathways and pathogenic mechanisms involved in Crohn's disease," he said. "Now that we are aware of the role of bacterial sensors in the disease, steps can be taken to develop a new treatment strategy."


'/>"/>

Contact: Mark Shainblum
mark.shainblum@mcgill.ca
514-398-2189
McGill University
Source:Eurekalert

Related medicine news :

1. Old gastrointestinal drug slows aging, McGill researchers say
2. Heart attack patients who stop statin risk death, say McGill researchers
3. Health researchers in McGill network receive $35.5 million in CIHR funding
4. McGill researchers report breakthrough in rapid malaria detection
5. McGill researchers link enzyme to breast cancer malignancy
6. Researchers Gain Insights Into Aging in Mice
7. Researchers discover target that could ease spinal muscular atrophy symptoms
8. Health-monitoring technology helps seniors live at home longer, MU researchers find
9. NC State researchers find new bartonella species that infects humans
10. Researchers Report Progress in Fight Against Fat
11. Mayo researchers offer new insight into effectiveness of procedure to stop heavy menstrual bleeding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... VA (PRWEB) , ... January 19, 2017 , ... Tribble ... services to the eastern Virginia region, is inaugurating a charity event to honor Chad ... , While on duty last year, Chad Phillip Dermyer and his fellow officers were ...
(Date:1/19/2017)... CA (PRWEB) , ... January 19, 2017 , ... ... taken in the 2017 Spring Create Real Impact contest from Impact Teen Drivers ... 17 at http://www.createrealimpact.com . , Educational grants totaling $15,000 will be ...
(Date:1/19/2017)... ... 2017 , ... Connecticut Dermatology Group (CDG) is proud and excited to welcome ... Dr. Kim brings an extensive background in cutting-edge dermatology care and research to ... welcome back Dr. Kim to the CDG team” said President and Managing Partner Dr. ...
(Date:1/19/2017)... ... January 19, 2017 , ... Infinity® Massage Chairs announced today that ... new sales and marketing strategies. Grover comes with a total of 15 years experience ... half years as Executive Vice President of Direct Sales at Traeger® Wood Pellet Grills. ...
(Date:1/18/2017)... Austin, TX (PRWEB) , ... January 18, 2017 , ... ... million people opened a global discussion about the benefits of fidgeting to relieve stress ... Lyon and Jym Daniel. Their Think Ink Pen had just completed a successful ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 18, 2017  Magnetic Insight Inc., leader in ... an agreement with inviCRO LLC to develop intuitive ... system based on inviCRO,s VivoQuant™ visualization and post ... a complete MPI solution package with the Momentum ... cell imaging in vivo. MPI is ...
(Date:1/19/2017)... 2017 The Academy of Managed Care ... (FDA) for its release today of draft guidance ... makers can proactively share clinical and economic information ... emerging therapies awaiting FDA approval. ... AMCP developed during two multi-stakeholder meetings last year ...
(Date:1/18/2017)... , Jan. 18, 2017  Aprima Medical ... records (EHR), practice management (PM) and revenue cycle ... the acquisition of a former reseller Healthcare Data ... of the agreement, Aprima will assume full support ... in 125 medical practices across 15 states. Financial ...
Breaking Medicine Technology: